POLARIS TRIAL
The POLARiS trial will investigate the clinical and cost benefit of two treatments for patients with major LARS who have previously undergone standard non-surgical treatment without improvement.
Buyer
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Value
£1,833,551
Published
11 May 2023
Closes
11 May 2023
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Limited
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
79314000
Feasibility study
Lots
Lot 1 POLARIS TRIAL
£1,833,551
14,000 cases of rectal cancer are diagnosed in the UK per year. The treatment for advanced rectal cancer is often radiotherapy+/-chemotherapy treatment followed by surgery. This provides good outcomes, with the cancer returning in less than 10% of people. However, the surgery can cause significant long-lasting problems, including problems with bowel, sexual...
Delivery: Cardiff and Vale of Glamorgan
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.